P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 24 May 2019 | 11:46 pm

Cancer research drives breast cancer treatment forward

Novartis team perseveres to develop more personalized approach to breast cancer therapy. more ...

Published 24 May 2019 | 10:30 pm

FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer

Piqray (alpelisib, formerly BYL719) plus fulvestrant nearly doubled median PFS (11.0 vs 5.7 months) in HR+/HER2- advanced breast cancer patients with a PIK3CA mutation more ...

Published 24 May 2019 | 10:17 pm

Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA more ...

Published 24 May 2019 | 6:49 pm

AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families

One-time treatment with Zolgensma (onasemnogene abeparvovec-xioi) is designed to replace lifetime of chronic therapy for all pediatric patients with SMA more ...

Published 24 May 2019 | 6:40 pm

AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)

SMA is a rare genetic disease that leads to progressive muscle weakness, paralysis and, when left untreated in its most severe form, permanent ventilation or death for most more ...

Published 24 May 2019 | 4:32 pm

Rising Star award winner Kara Price shares how she encourages other women in STEM

Kara Price still remembers the day she changed her mind about becoming a doctor. It was the day she had to dissect a rat under anesthesia in her college biology class. more ...

Published 24 May 2019 | 2:17 pm

Tumour-agnostic treatments

Today, a new paradigm for cancer care may be emerging, where treatments are identified based on the unique genetic makeup of an individual's tumour, regardless of where more ...

Published 24 May 2019 | 12:22 pm

Strengthening Takeda's Global Reach by Sustaining Core Values

Maintaining deep-rooted values and taking steps to invest in people is critical in times of rapid globalization. more ...

Published 24 May 2019 | 1:05 am

Forging new paths in R&D for cancer treatments

Sanofi Focuses Rapidly Growing Oncology Efforts on Recent Discoveries more ...

Published 23 May 2019 | 6:09 pm

GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019